ARCHIVES

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

Two Doses of the Vaccine Cervarix Can Be As Effective As Three

September 30, 2011

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”

January 7, 1977

Murray Copeland Display Dedicated

March 18, 1983

NCI To Recompete NSABP in 1995, Chabner tells Senate

May 20, 1994

FDA Approves Afinitor Tablets For Advanced Breast Cancer

August 31, 2012